Arbutus Biopharma stockABUS
Arbutus Biopharma trades at $3.67, 32.7% below its 52-week high (Aug 21, 2026). The price is below its 50- and 200-day averages, a downtrend. −23.7% year to date, −20.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 11, 2026.
Ratings, candles, signals and the screener for ABUS — after you log in
Open the terminalFrequently asked questions about Arbutus Biopharma
What is the Arbutus Biopharma stock price?
At the close on Nov 5, 2026: $3.67 (−9.61% on the day). 52-week high: $5.45 on Aug 21, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Arbutus Biopharma report earnings?
The next quarterly report is on Nov 11, 2026. Last quarter, earnings per share changed −400% year over year, revenue −91%.
Does Arbutus Biopharma pay dividends?
No, Arbutus Biopharma does not pay dividends.
Where does Arbutus Biopharma trade and how to buy it?
Ticker ABUS, exchange Nasdaq, listed since 2010. You can buy it through a broker with access to US exchanges.
Should I buy Arbutus Biopharma now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ABUS are in the terminal after you log in.